Biomarkers | Optimum cut-off | Sensitivity (%) | Specifificity (%) |
---|---|---|---|
PC vs. Controls | |||
CA19-9 | ≥ 57 U/mL | 80.21 | 75 |
ATX | ≥ 286 ng/mL | 78.95 | 80 |
LPA | ≥ 10.7 µg/mL | 91.74 | 69.4 |
TS1 + TS2 vs. Controls | |||
CA19-9 | ≥ 57 U/mL | 77.33 | 75 |
ATX | ≥ 286 ng/mL | 65.33 | 80 |
LPA | ≥ 10.7 µg/mL | 80.67 | 69.4 |
TS3 + TS4 vs. Controls | |||
CA19-9 | ≥ 57 U/mL | 82.26 | 75 |
ATX | ≥ 286 ng/mL | 89.6 | 80 |
LPA | ≥ 10.7 µg/mL | 95.65 | 69.4 |